There are 2789 resources available
846P - Predictive and prognostic values of serum VEGF in patients with multiple myelomas receiving bortezomib-based therapy
Presenter: Salah Khallaf
Session: ePoster Display
787P - Endotoxicosis and properties of erythrocyte membranes in patients with cervical cancer receiving combination therapy with dendritic cell-based immunotherapy
Presenter: Irina Goroshinskaya
Session: ePoster Display
849P - Demographics of Langerhans cell histiocytosis patients who died during the 2010-2017
Presenter: Sai Giridhar Gundepalli
Session: ePoster Display
850P - Acute lymphoblastic leukemia patients receiving prophylactic cranial irradiation by volumetric modulated ARC therapy with hippocampal sparing: Dosimetric analysis
Presenter: Ambedkar Yadala
Session: ePoster Display
851P - Treatment efficacy for adults with relapsed or refractory acute lymphoblastic leukemia: A systematic literature review (SLR)
Presenter: Yun Liu
Session: ePoster Display
852P - Feasibility and safety of HiDAC in AML patients who have achieved CR with hypomethylating agents: Prospective study
Presenter: Sanjo Varghese
Session: ePoster Display
Resources:
Abstract
853P - PRAME expression and ImmTAC TCR bispecific sensitivity in acute myeloid leukaemia in the presence and absence of the hypomethylating agent decitabine
Presenter: Camille Britton-Rivet
Session: ePoster Display
854P - Final results of a phase II study of tipifarnib in chronic myelomonocytic leukemia (CMML) and other myelodysplastic/myeloproliferative neoplasms (MDS/MPN)
Presenter: Mrinal Patnaik
Session: ePoster Display
796P - Association between biomarkers and clinical outcomes of lenvatinib (L) + pembrolizumab (P) in advanced endometrial cancer (EC): Results from KEYNOTE-146/study 111
Presenter: Vicky Makker
Session: ePoster Display